Income statement, balance sheet and cash flow statement for the last 1 fiscal years, taken from the XBRL data Basel Medical Group Ltd files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2025
Revenue
8.9
Interest expense
0.16
Pre-tax income
-8.69
Income tax
-0.33
Net income to minority interests
-0
Net income
-8.36
EPS, basic
-0.45
EPS, diluted
-0.45
Balance sheet
FY2025
Cash and equivalents
2.39
Receivables
7.46
Inventory
0.38
Total current assets
10.5
Property, plant and equipment
0.31
Lease right-of-use assets
3.89
Total assets
14.7
Accounts payable
5.17
Short-term debt
1.67
Total current liabilities
7.99
Lease liabilities
2.32
Total liabilities
10.4
Retained earnings
-2.7
Minority interests
0
Total equity
4.28
Total liabilities and equity
14.7
Cash flow statement
FY2025
Net income
-8.36
Cash from operations
-3.18
Capital expenditures
-0.44
Cash from investing
-8.57
Debt repaid
-6.5
Cash from financing
13
Exchange rate effect
-0.36
Free cash flow
-3.62
Interest paid
0.16
Income taxes paid
0.51
Key metrics
Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $3.70 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Pre-tax margin
-97.6%
Pre-tax income / revenue.
Net margin
-94.0%
Net income / revenue.
FCF margin
-40.6%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-35.7%
Cash from operations / revenue.
Return on assets (ROA)
-56.9%
Net income / average total assets.
Capex / revenue
4.9%
Capital expenditures / revenue.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.31x
Current assets / current liabilities.
Quick ratio
1.23x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.30x
(Cash + short-term investments) / current liabilities.
Liabilities / assets
70.9%
Total liabilities / total assets.
Working capital
$2.5M
Current assets - current liabilities.
Efficiency
Metric
Value
How it is calculated
Asset turnover
0.61x
Revenue / average total assets.
Fixed asset turnover
29.1x
Revenue / average property, plant and equipment.
Receivables turnover
1.19x
Revenue / average receivables.
Days sales outstanding
306 days
365 x average receivables / revenue.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.45
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-$0.45
Net income per basic share, as reported (split-adjusted).
Valuation
Metric
Value
How it is calculated
Market cap
$5.8M
Share price x shares outstanding.
Enterprise value
$3.4M
Market cap + total debt - cash - short-term investments.
P/S
0.65x
Market cap / revenue.
EV/Sales
0.38x
Enterprise value / revenue.
FCF yield
-62.5%
Free cash flow / market cap.
Earnings yield
-144.4%
Net income / market cap (the inverse of P/E).
What was Basel Medical Group Ltd's revenue in fiscal 2025?
Basel Medical Group Ltd reported revenue of $8.9M for fiscal 2025.
Was Basel Medical Group Ltd profitable in fiscal 2025?
No. It reported a net loss of $8.4M.
How much free cash flow did Basel Medical Group Ltd generate in fiscal 2025?
Cash from operations of $3.2M minus capital expenditures of $437.9K left free cash flow of -$3.6M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.